TY - JOUR
T1 - The anti-inflammatory and antioxidant properties of n-3 PUFAs
T2 - Their role in cardiovascular protection
AU - Oppedisano, Francesca
AU - Macrì, Roberta
AU - Gliozzi, Micaela
AU - Musolino, Vincenzo
AU - Carresi, Cristina
AU - Maiuolo, Jessica
AU - Bosco, Francesca
AU - Nucera, Saverio
AU - Zito, Maria Caterina
AU - Guarnieri, Lorenza
AU - Scarano, Federica
AU - Nicita, Caterina
AU - Coppoletta, Anna Rita
AU - Ruga, Stefano
AU - Scicchitano, Miriam
AU - Mollace, Rocco
AU - Palma, Ernesto
AU - Mollace, Vincenzo
N1 - Publisher Copyright:
© 2020 by the authors.
PY - 2020/9
Y1 - 2020/9
N2 - Polyunsaturated fatty acids (n-3 PUFAs) are long-chain polyunsaturated fatty acids with 18, 20 or 22 carbon atoms, which have been found able to counteract cardiovascular diseases. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in particular, have been found to produce both vaso- and cardio-protective response via modulation of membrane phospholipids thereby improving cardiac mitochondrial functions and energy production. However, antioxidant properties of n-3 PUFAs, along with their anti-inflammatory effect in both blood vessels and cardiac cells, seem to exert beneficial effects in cardiovascular impairment. In fact, dietary supplementation with n-3 PUFAs has been demonstrated to reduce oxidative stress-related mitochondrial dysfunction and endothelial cell apoptosis, an effect occurring via an increased activity of endogenous antioxidant enzymes. On the other hand, n-3 PUFAs have been shown to counteract the release of pro-inflammatory cytokines in both vascular tissues and in the myocardium, thereby restoring vascular reactivity and myocardial performance. Here we summarize the molecular mechanisms underlying the anti-oxidant and anti-inflammatory effect of n-3 PUFAs in vascular and cardiac tissues and their implication in the prevention and treatment of cardiovascular disease.
AB - Polyunsaturated fatty acids (n-3 PUFAs) are long-chain polyunsaturated fatty acids with 18, 20 or 22 carbon atoms, which have been found able to counteract cardiovascular diseases. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in particular, have been found to produce both vaso- and cardio-protective response via modulation of membrane phospholipids thereby improving cardiac mitochondrial functions and energy production. However, antioxidant properties of n-3 PUFAs, along with their anti-inflammatory effect in both blood vessels and cardiac cells, seem to exert beneficial effects in cardiovascular impairment. In fact, dietary supplementation with n-3 PUFAs has been demonstrated to reduce oxidative stress-related mitochondrial dysfunction and endothelial cell apoptosis, an effect occurring via an increased activity of endogenous antioxidant enzymes. On the other hand, n-3 PUFAs have been shown to counteract the release of pro-inflammatory cytokines in both vascular tissues and in the myocardium, thereby restoring vascular reactivity and myocardial performance. Here we summarize the molecular mechanisms underlying the anti-oxidant and anti-inflammatory effect of n-3 PUFAs in vascular and cardiac tissues and their implication in the prevention and treatment of cardiovascular disease.
KW - Anti-inflammatory response
KW - Cardiovascular diseases
KW - Endogenous antioxidants
KW - n-3 PUFAs
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=85090799638&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090799638&partnerID=8YFLogxK
U2 - 10.3390/biomedicines8090306
DO - 10.3390/biomedicines8090306
M3 - Review article
AN - SCOPUS:85090799638
SN - 2227-9059
VL - 8
JO - Biomedicines
JF - Biomedicines
IS - 9
M1 - 306
ER -